Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Siemens Healthineers - Laboratory Diagnostics

Provides advanced laboratory diagnostics solutions for the medical industry read more Featured Products: More products

Download Mobile App





Siemens Debuts New Drug Testing Analyzer

By LabMedica International staff writers
Posted on 29 Jul 2025

At the ADLM 2025 Clinical Lab Expo, Siemens Healthineers (Forchheim, Germany) is demonstrating what is achievable for laboratory testing with human-centered engineering and automation. More...

Successful automation addresses the specific needs of each lab, while standardizing tasks that safeguard quality and safety. Siemens consolidates 25 tasks directly into the Atellica systems, which will be on display at ADLM 2025. Chip, sensors, and lines of code work together to help simplify tasks and minimize hands-on time. In minutes, a single technologist can manage calibration and QC, daily sorting, and archiving processes—tasks that historically may have taken hours—to improve throughput and reduce waste. Atellica Integrated Automation, for example, can reduce end-to-end manual workflow steps by 75% and 65% of samples run on Atellica Sample Handler can see faster turnaround times than competitor systems.

Attendees also will see how the Atellica Portfolio is supporting wider health system efficiencies. The ability to shift employees from location to location is increasingly important to maintain the required staffing to keep laboratories operational. The industry-leading modular and connectivity options Siemens offers seamlessly integrate advanced automation into small and mega-labs alike. The Atellica Solution and Atellica CI Analyzer offer a consistent user experience so that entry-level professionals and experienced medical technologists can be ready to process samples anywhere in the network. Health systems also benefit from the analyzers’ cost savings and sustainability—they consume the least water compared to other integrated analytical systems, and 98.3% percent of Atellica Solution materials can be recycled.

Visitors to the Siemens booth at ADLM 2025 can discover specialty lab solutions, including the debut of the new Atellica DT 250 Drug Testing Analyzer, alongside automated hematology and hemostasis solutions, plasma proteins, and allergy testing. The Atellica DT 250 Analyzer combines trusted, proven Syva EMIT technologies with the practicality and reliability you need to meet the high-stakes demands of today’s drug-testing facilities. This small benchtop system offers the throughput and onboard sample capacity previously only available in larger, floor-standing models.

Attendees will be introduced to FlexLab X1, the next-generation total lab automation solution that offers unrivaled multidisciplinary consolidation, intelligent software, and the highest throughput on the market. Visitors to the Siemens booth can also explore the company’s point-of-care testing solutions, which are easy to use, can improve efficiency, and enable quicker results wherever testing takes place.

Siemens is also presenting educational workshops led by top clinicians, laboratorians, and patients. The liver disease workshop will join a patient’s voice with the expertise of a clinician and laboratorian, highlighting the strength of a multidisciplinary approach. The cardiac workshop will discuss how early detection and prognostic insights can influence outcomes and care pathways. Throughout the show, clinical experts from Siemens will present scientific posters on various research topics, including automation and analytical techniques, cardiac markers, clinical and diagnostic immunology, endocrinology and metabolism, pediatric and maternal fetal medicine, therapeutic drug monitoring and toxicology, and tumor markers and cancer diagnostics.

Related Links:
Siemens Healthineers


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Portable Electronic Pipette
Mini 96
Laboratory Software
ArtelWare
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.